Full history for every metric is available with a Kvantra account
U.S. NeuroSurgical Holdings, Inc. (USNU)
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|
| Total revenue | $m | 3 | 1 | 0 | 0 | 0 | 1 |
| Operating profit | $m | -4 | |||||
| Net profit | $m | 1 | -1 | -2 | -1 | -2 | -8 |
| EPS reported | $ | -0.35 | |||||
| Operating cashflow per share | $ | -0.13 | |||||
| Capex per share | $ | 0.00 | |||||
| FCF per share | $ | -0.13 | |||||
| Free cash flow | $m | -3 | |||||
| Net debt | $m | -4 | |||||
| Book value equity | $m | 5 | |||||
| Book value per share | $ | 0.23 | |||||
| Number of shares | m | 22.61 | |||||
| DPS (TTM paid) | $ | 0.00 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|
| Value | |||||||
| P/E TTM | x | - | |||||
| P/B LTM | x | 4.26 | |||||
| P/S LTM | x | 22.08 | |||||
| P/FCF LTM | x | -7.69 | |||||
| EV/EBITDA LTM | x | 460.82 | |||||
| EV/Sales LTM | x | 18.45 | |||||
| Earnings Yield LTM | % | -34.51% | |||||
| FCF Yield | % | -13.00% | |||||
| Quality | |||||||
| ROE | % | -146.88% | |||||
| ROIC | % | -71.60% | |||||
| Operating margin | % | -374.90% | |||||
| Gross margin | % | 11.52% | |||||
| FCF/Sales | % | -287.11% | |||||
| Growth and momentum | |||||||
| EPS Growth YoY | % | - | |||||
| Sales Growth YoY | % | - | |||||
| Net Income Growth YoY | % | - | |||||
| FCF Growth | % | - | |||||
| Operating Profit Growth | % | - | |||||
| Dividend and capital structure | |||||||
| Dividend Yield | % | 0.00% | |||||
| Dividend Growth | % | 0.00% | |||||
| Payout Ratio | % | 0.00% | |||||
| FCF/Debt | x | -77.37 | |||||
| Net Debt/EBITDA | x | -90.73 | |||||
| EBIT/Net interest | x | 0.00 | |||||
| Net debt/market cap | % | -16.45% | |||||
| Net debt/Equity | x | -0.70 | |||||
| Gross debt/equity | x | 0.01 | |||||
Company overview
U.S. NeuroSurgical Holdings, Inc. oversees and operates specialized facilities for stereotactic radiosurgery, leveraging gamma knife technology. This gamma knife system functions as a precise, non-invasive radiosurgical instrument, effectively treating brain tumors and various cerebral malformations. The company, which originated in 1993, maintains its principal office in Rockville, Maryland.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
U.S. NeuroSurgical Holdings, Inc. (USNU)
U.S. NeuroSurgical Holdings, Inc. oversees and operates specialized facilities for stereotactic radiosurgery, leveraging gamma knife technology. This gamma knife system functions as a precise, non-invasive radiosurgical instrument, effectively treating brain tumors and various cerebral malformations. The company, which originated in 1993, maintains its principal office in Rockville, Maryland.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free